Cellular Biomedicine Group, Inc. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Sponsored Collaborative Research Agreement with Duke University, executed on September 21, 2020 (Filed With SEC on November 9, 2020)
- BRIDGELOAN AGREEMENT (Filed With SEC on October 26, 2020)
- Description of Securities (Filed With SEC on February 28, 2020)
- Clinical Trial Agreement (Filed With SEC on March 14, 2016)
- Patent Transfer Agreement among China Pharmaceutical University (as the Transferor) and Cellular Biomedicine Group (Shanghai) Ltd. (As the Transferee) November 16, 2015 (Filed With SEC on March 14, 2016)
- Technology Transfer Contract (Filed With SEC on March 14, 2016)
- Form of Lockup Agreement (Filed With SEC on October 2, 2014)
- Technology Transfer Agreement, dated September 1, 2014 (Filed With SEC on October 2, 2014)
- Framework Agreement, dated August 2, 2014 (with unofficial summary translation) (Filed With SEC on October 2, 2014)
- Option Deed (Filed With SEC on July 8, 2014)
- CELLULAR BIOMEDICINE GROUP, INC. [Letterhead] [Date] (Filed With SEC on April 15, 2014)
- Cellular Biomedicine Group [_____________] (Filed With SEC on February 12, 2013)
- CONSULTINGAGREEMENT (Filed With SEC on May 23, 2011)
- EastBridge Investment Group Corp.CONFIDENTIAL (Filed With SEC on November 12, 2010)
- ListingAgreement (Filed With SEC on April 15, 2010)
- US Listing Agreement (Filed With SEC on April 15, 2010)
- 1 2 3 4 5 (Filed With SEC on April 15, 2010)
